| Series | Current NAVPS | Prior NAVPS | NAVPS Change | Net Asset Value | Last Updated | ||
|---|---|---|---|---|---|---|---|
| A | $ 0.0000 | $ 0.0000 | nan% | $ | 2023-07-24 | ||
| F | $ 0.0000 | $ 0.0000 | nan% | $ | 2023-07-24 | ||
| O | $ 0.0000 | $ 0.0000 | nan% | $ | 2023-07-24 | ||
| T8A | $ 0.0000 | $ 0.0000 | nan% | $ | 2023-07-24 | * Closed to new purchases. |
| Series | 1 Month | 3 Month | 6 Month | Year To Date | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| A | 1.1 | 0.1 | 12.2 | 7.5 | 2.3 | 3.5 | 1.1 | 3.8 | 2.4 | 2008-05-31 |
| F | 1.2 | 0.7 | 12.7 | 8.2 | 3.3 | 4.6 | 2.2 | 4.9 | 3.5 | 2008-05-31 |
| T8A | 1.1 | 0.1 | 12.2 | 7.4 | 2.2 | 3.4 | 1.1 | 3.7 | 2.3 | 2008-05-31 |
| CALENDAR RETURN | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
| A | -29.4% | 11.2 | 22.1 | 11.4 | (9.6) | 11.9 | (10.4) | 17.7 | 3.3 | 27.2 | 15.6 |
| B | 10.4 | 21.4 | 10.8 | (10.2) | 11.1 | (11.0) | 17.1 | 2.7 | 26.4 | 14.9 | |
| C | 2.8 | 26.4 | 14.8 | ||||||||
| F | -29.0% | 12.3 | 23.3 | 12.7 | (8.7) | 13.4 | (9.5) | 18.9 | 4.4 | 28.5 | 16.9 |
| T8A | -29.4% | 11.0 | 21.8 | 11.5 | (9.6) | 11.7 | (10.6) | 17.8 | 3.3 | 27.1 | 15.7 |
| T8B | 2.9 | 26.8 | 15.0 | ||||||||
| T8C | 14.8 | ||||||||||
| L | 10.5 | 21.4 | 10.8 | (10.1) | 11.1 | (11.0) | 17.2 | 2.8 | 26.6 | 15.0 | |
| Benchmark | -11.9% | 17.3 | 14.6 | 21.8 | (7.4) | 16.9 | (2.8) | 15.7 | 2.5 | 33.8 | 16.6 |
| HOLDINGS | ||
| 1 | Mastercard Inc. | 3.4 |
| 2 | Visa Inc. | 3.3 |
| 3 | AstraZeneca | 3.2 |
| 4 | L'Oreal | 3.2 |
| 5 | Linde plc | 3.0 |
| 6 | Evoqua Water Technologies Corp. | 3.0 |
| 7 | Thermo Fisher Scientific Inc. | 2.9 |
| 8 | ASML Holding NV | 2.8 |
| 9 | Adobe Inc. | 2.7 |
| 10 | Halma plc | 2.6 |
| Total | 30.1% | |
| A | B | F | L | T8A |
| 2.85% | 3.52% | 1.81% | 3.47% | 3.02% |
